Regulatory Filings • May 4, 2023
Regulatory Filings
Open in ViewerOpens in native device viewer
Receipt of approval of Superba Krill Oil in the Korean market
4 May 2023: Reference is made to the stock exchange announcement on 26 April 2023 by Aker BioMarine ASA regarding the expected approval of Superba krill oil in South Korea. Aker BioMarine and its long-term local partner have today received the final approval from the Korean Ministry of Food and Drug Safety for Superba krill oil as Health Functional Food in South Korea.
For further information, please contact
Katrine Klaveness, CFO
Mobile: +47 991 58 915
Email: [email protected]
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.